Smart Alert System for Hospital Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smart alert system that assists doctors in the ICU by providing real-time alerts about unusual patient care behavior. The trial aims to determine if these alerts can enhance decision-making at the bedside. It includes two groups: one where doctors receive the alerts (Revealed Alerts) and another where they do not (Unrevealed Alerts). Patients currently in the Presbyterian and Montefiore ICUs can participate in this trial. As an unphased trial, it offers patients the chance to contribute to innovative research that could improve ICU care for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this smart alert system is safe for hospital care?
Research has shown that alert systems in hospitals can enhance patient care safety and quality. For instance, a large study involving 13 million patients found that safety improved when healthcare staff used these alerts. However, while alerts contribute to safety, they can sometimes overwhelm staff, leading to "alert fatigue." This occurs when too many alerts make it difficult for staff to focus on the most critical ones.
Overall, these alert systems are safe for hospital use, but there is potential for improvement. Although no specific problems have been reported from using these systems, balancing the number of alerts is crucial to prevent fatigue.12345Why are researchers excited about this trial?
Researchers are excited about the Smart Alert System for Hospital Care because it aims to revolutionize how hospitals manage patient alerts. Unlike traditional systems that often overwhelm staff with too many alerts, this system differentiates between "Revealed Alerts" and "Unrevealed Alerts," potentially offering a more efficient way to prioritize critical patient information. This approach could significantly reduce alert fatigue among healthcare professionals, allowing them to focus on the most urgent cases and ultimately improving patient outcomes. By enhancing the clarity and urgency of alerts, this system could streamline hospital workflows and ensure timely medical interventions.
What evidence suggests that this trial's alert system could be effective for improving clinician behavior?
This trial will compare two types of digital alert systems: Revealed Alerts and Unrevealed Alerts. Research has shown that digital alert systems can significantly improve hospital care by shortening hospital stays and aiding doctors in better patient management. For instance, studies have found that automated alerts assist in managing conditions like sepsis by providing timely warnings, leading to improved health outcomes. One study discovered that electronic alerts helped doctors recognize and begin treating acute kidney injury (AKI) earlier, although it did not directly improve kidney function. These findings suggest that such systems can make a real difference by quickly notifying healthcare providers, potentially enhancing patient safety and care efficiency.678910
Who Is on the Research Team?
David Huang, MD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for critically ill patients being transferred to a healthcare facility. Specific eligibility criteria are not provided, so it's unclear who exactly can participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Alert Evaluation
Real-time evaluation of outlier alerts generated by an AI model from EHR data, reviewed by ICU clinicians for clinical relevance.
Follow-up
Participants are monitored for safety and effectiveness after alert interventions
Study Completion
Evaluation of alert system performance and clinical outcomes over the study period
What Are the Treatments Tested in This Trial?
Interventions
- Revealed Alerts
- Unrevealed Alerts
Find a Clinic Near You
Who Is Running the Clinical Trial?
David T Huang
Lead Sponsor
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Collaborator